178 ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2006 CROSS-REFERENCE TO FORM 20-F The information in this document that is referenced on this page is included in AstraZenecas Form 20-F for 2006 2006 Form 20-F and is filed with the Securities and Exchange Commission SEC.
The 2006 Form 20-F is the only document intended to be incorporated by reference into any filings by AstraZeneca under the Securities Act of 1933, as amended.
References to major headings include all information under such major headings, including subheadings.
References to subheadings include only the information contained under such subheadings.
Graphs are not included unless specifically identified.
The 2006 Form 20-F has not been approved or disapproved by the SEC, nor has the SEC passed comment upon the accuracy or adequacy of the 2006 Form 20-F.
The 2006 Form 20-F filed with the SEC may contain modified information and may be updated from time to time.
Item Page Item Page 3 Key Information 8 Financial Information A.
Consolidated statements and other Financial Highlights 6 financial information Group Financial Record IFRS 163 Financial Statements excluding Directors Shareholder Information 165 responsibilities on page 96 and Auditors D. Risk factors 172 opinion on page 97 98 B.
Significant changes 4 Information on the Company Note 28 Statutory and other information 146 A.
History and development of the Company 177 9 The Offer and Listing Financial Review Investments, divestments and capital expenditure 57, 69 A4.
Price history of listed stock Note 7 Property, plant and equipment 110 Shareholder Information 165 Note 22 Acquisitions of business operations 121 C. Markets Note 23 Disposal of business operations 123 Shareholder Information 165 B.
Business overview 10 Additional Information Business Review 8 B.
Memorandum and Articles of Association 177 C. Organisational structure C. Material contracts n a Directors Report Governance 71 D. Exchange controls and other limitations Principal Subsidiaries 148 affecting security holders 169 D. Property, plant and equipment E. Taxation 168 Business Review Main Facilities 49 H. Documents on display 168 5 Operating and Financial Review and Prospects I.
Subsidiary information A-F. Business Review 8 Principal Subsidiaries 148 A-F. Financial Review 53 11 Quantitative and Qualitative Disclosures about Market Risk Note 15 Financial instruments 115 Financial Review Financial Risk Management 6 Directors, Senior Management and Employees Policies Treasury 60 A.
Directors and senior management 12 Description of Securities other than Equity Securities n a Board of Directors 80 B.
Compensation 13 Defaults, Dividend Arrearages and Delinquencies n a Directors Remuneration Report 82 14 Material Modifications to the Rights of Security Note 24 Post-retirement benefits 123 Holders and Use of Proceeds n a Note 28 Statutory and other information 146 C. Board practices 15 Controls and Procedures Board of Directors 80 Directors Report Internal controls and Directors Remuneration Report 82 management of risk 75 Directors Report Governance 71 16 [Reserved] Audit Committee 72 A.
Audit Committee financial expert D. Employees Audit Committee 72 Note 25 Employee costs and share option B.
Code of ethics plans for employees 128 Directors Report Code of Conduct 76 Directors Report People 48 C. Principal accountant fees and services E. Share ownership Note 28 Statutory and other information 146 Directors Remuneration Report D. Exemptions from the listing standards Directors Interests in Shares 91 for audit committees n a Note 25 Employee costs and E. Purchases of equity securities by the issuer share option plans for employees 128 and affiliated purchasers 7 Major Shareholders and Related Party Transactions Note 29 Share capital of parent company 147 A.
Major shareholders 18 Financial Statements Shareholder Information Major shareholdings 166 Financial Statements excluding Directors responsibilities B.
Related party transactions on page 96 and Auditors opinion on page 97 98 Shareholder Information Related party transactions 167 Note 28 Statutory and other information 146
